Bisphosphonates and Atypical Fractures of Femur
Author
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-03-31
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs.
Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates.
Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well.
However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies.
American Psychological Association (APA)
Yli-Kyyny, Tero. 2011. Bisphosphonates and Atypical Fractures of Femur. Journal of Osteoporosis،Vol. 2011, no. 2011, pp.1-5.
https://search.emarefa.net/detail/BIM-496204
Modern Language Association (MLA)
Yli-Kyyny, Tero. Bisphosphonates and Atypical Fractures of Femur. Journal of Osteoporosis No. 2011 (2011), pp.1-5.
https://search.emarefa.net/detail/BIM-496204
American Medical Association (AMA)
Yli-Kyyny, Tero. Bisphosphonates and Atypical Fractures of Femur. Journal of Osteoporosis. 2011. Vol. 2011, no. 2011, pp.1-5.
https://search.emarefa.net/detail/BIM-496204
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-496204
